GALENA BIOPHARMA INC's ticker is GALE and the CUSIP is 363256504. A total of 61 filers reported holding GALENA BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $70,000 | – | 36,205 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 2,702,228 | $953,000 | 0.06% |
Crescent Grove Advisors, LLC | 120,000 | $42,000 | 0.01% |
DAFNA Capital Management LLC | 46,145 | $16,000 | 0.01% |
TWO SIGMA SECURITIES, LLC | 34,954 | $12,000 | 0.00% |
MEEDER ASSET MANAGEMENT INC | 14,646 | $5,000 | 0.00% |
Renaissance Technologies | 2,769,786 | $977,000 | 0.00% |
Winfield Associates, Inc. | 3,000 | $1,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 500 | $0 | 0.00% |
WELLS FARGO & COMPANY/MN | 19,729 | $7,000 | 0.00% |
NORTHERN TRUST CORP | 39,908 | $14,000 | 0.00% |